Early Metabolic Response Evaluation With 18-FDG PET-CT in Esophageal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Both
Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)
Both
Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)
Trial Information
Early Metabolic Response Evaluation With 18-FDG PET-CT in Esophageal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Esophagectomy
Inclusion Criteria:
- locally advanced esophageal cancer (cT2-4 N0/+)
Exclusion Criteria:
- PET-CT not performed at UZLeuven
- Other tumor types
- Distant metastases (organ)
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
early metabolic response to predict pathological response and outcome
Outcome Description:
assess the value of early metabolic response with 18-FDG-PET-CT (i.e. a decrease of ≥ 35% of SUVmean) after a single cycle of chemotherapy followed by neoadjuvant CRT and esophagectomy as a tool to predict pathological response and outcome in patients with cT2-4N0/+ carcinoma of the esophagus and GE-junction (GEJ).
Authority:
Belgium: Institutional Review Board
Study ID:
G.0175.03
NCT ID:
NCT01269970
Start Date:
January 2004
Completion Date:
December 2009
Related Keywords:
- Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)
- Adenocarcinoma
- Adenocarcinoma, Mucinous
- Carcinoma
- Carcinoma, Squamous Cell
- Esophageal Diseases
- Esophageal Neoplasms
Name | Location |
|---|
